Drug Safety

, Volume 37, Issue 8, pp 609–616 | Cite as

Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports

  • Alwis Nazir
  • Takashi Ichinomiya
  • Nobuteru Miyamura
  • Yasuaki Sekiya
  • Yasutomi Kinosada
Original Research Article



In the treatment of depression, it is essential to monitor for early warnings of suicide.


The aim of this study was to identify the symptoms that would suggest a high suicide risk by analyzing data obtained from the US Food and Drug Administration Adverse Event Reporting System (FAERS) of selective serotonin reuptake inhibitors.


Using FAERS reports from 1997 to the second quarter of 2012, we constructed the co-occurrence network of adverse events. From this network, we extracted the events that were strongly connected to suicidal events (suicidal attempts, suicidal ideation, suicidal behavior, and complete suicide) by means of the community detection method.


We succeeded in obtaining a list of suicide-related adverse events. Owing to the randomness inherent in the algorithms of community detection, we found that the obtained list differed according to each trial of analysis. However, the lists we derived show considerable efficiency in identifying suicidal events.


The network analysis appears to be a promising method for identifying signals of suicide.


  1. 1.
    Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205–28.PubMedCrossRefGoogle Scholar
  2. 2.
    Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 1999;156:181–9.PubMedGoogle Scholar
  3. 3.
    Reihmer Z. Suicide and bipolar disorder. In: Zarate CA, Manji HK, editors. Bipolar depression: molecular neurobiology, clinical diagnosis and pharmacotherapy. Basel: Birkhäuser; 2009. p. 47–56.Google Scholar
  4. 4.
    Vaswani MK, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:85–102.PubMedCrossRefGoogle Scholar
  5. 5.
    Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002;25:381–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf. 2005;4:929–48.PubMedCrossRefGoogle Scholar
  7. 7.
    Piccinni C, Motola D, Marchesini G, Poluzzi E. Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting. Diabetes Care. 2011;34:1369–71.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Gunguly N, Deutsh A, Mukherjee A, editors. Dynamics on and of complex networks: application to biology, computer science, and the social sciences. Basel: Birkhäuser; 2009.Google Scholar
  9. 9.
    Liljeros F, Edling CR, Amaral LAN, Stanley HE, Aberg Y. The web of human sexual contacts. Nature. 2001;411:907–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Pastor-Satorras R, Vespignani A. Immunization of complex networks. Phys Rev E. 2002;65:036104.CrossRefGoogle Scholar
  11. 11.
    Alon U. An introduction to systems biology: design principles of biological circuits. London: Chapman and Hall; 2006.Google Scholar
  12. 12.
    Barabási AL. Network medicine: from obesity to the “diseasome”. N Engl J Med. 2007;357:404–7.PubMedCrossRefGoogle Scholar
  13. 13.
    DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting systems. Am Stat. 1999;53:177–90.Google Scholar
  14. 14.
    Harpaz R, Chase HS, Friedman C. Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinform. 2010;11(Suppl. 9):S7.CrossRefGoogle Scholar
  15. 15.
    Newman MEJ. Modularity and community structure in networks. Proc Natl Acad Sci USA 2006;103:8577–8582.Google Scholar
  16. 16.
    American Society of Health-System Pharmacists. AHFS drug information 2010. Maryland: American Society of Health-System Pharmacists; 2010.Google Scholar
  17. 17.
    Wishart DS, Knox C, Guo AC, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36:D901–6.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Newman MEJ. Finding and evaluating community structure in networks. Phys Rev E. 2004;69:026113.CrossRefGoogle Scholar
  19. 19.
    Guimerà R, Sales-Pardo M, Amaral LAN. Modularity from fluctuations in random graphs and complex networks. Phys Rev E. 2004;70:R025101.CrossRefGoogle Scholar
  20. 20.
    Rosvall M, Bergstrom CT. An information-theoretic framework for resolving community structure in complex network. Proc Natl Acad Sci USA. 2007;104:7327–31.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Blondel VD, Guillaume JL, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J Stat Mech. 2008;2008:P10008.Google Scholar
  22. 22.
    Fortunato S, Barthélemy M. Resolution limit in community detection. Proc Natl Acad Sci USA. 2007;104:36–41.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Lambiotte R, Delvenne J -C, Barahona M. Laplacian dynamics and multiscale modular structure in networks [internet]. 2008. arXiv:0812.1770.Google Scholar
  24. 24.
    Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. In: International AAAI conference on weblogs and social media; 17–20 May 2009, San Jose, USA. http://www.aaai.org/ocs/index.php/ICWSM/09/paper/view/154. Accessed 23 Mar 2014.
  25. 25.
    Huang L, Zalkikar J, Tiwari RC. A likelihood ratio test based method for signal detection with application to FDA’s drug safety data. J Am Stat Assoc. 2011;106:1230–41.CrossRefGoogle Scholar
  26. 26.
    Huang L, Guo T, Zalkikar JN, Tiwari RC. A review of statistical methods for safety surveillance. Ther Innov Regul Sci. 2014;48:98–108.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Alwis Nazir
    • 1
    • 2
  • Takashi Ichinomiya
    • 1
    • 3
  • Nobuteru Miyamura
    • 1
  • Yasuaki Sekiya
    • 1
  • Yasutomi Kinosada
    • 1
    • 3
  1. 1.The United Graduate School of Drug Discovery and Medical Information Sciences of Gifu UniversityGifuJapan
  2. 2.State Islamic University of Sultan Syarif Kasim RiauPekanbaruIndonesia
  3. 3.Department of Biomedical InformaticsGifu University School of MedicineGifuJapan

Personalised recommendations